The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Open accessAbstract
Fibroblast growth factor (FGF)21 is an endocrine hormone that is expressed in multiple tissues and functions physiologically to maintain energy homeostasis. FGF21 is being pursued as a therapeutic target for diabetes and obesity because of its rapid and potent effects on improving insulin sensitivity. However, whether FGF21 enhances insulin sensitivity under physiologic conditions remains unclear. Here, we show that liver-derived FGF21 enters the circulation during fasting but also remains present and functional during the early stage of refeeding. After a prolonged fast, FGF21 acts as an insulin sensitizer to overcome the peripheral insulin resistance induced by fasting, thereby maximizing glucose uptake. Likewise, FGF21 is produced from the liver during overfeeding and mitigates peripheral insulin resistance. DIO FGF21 liver-specific knockout, but not FGF21 adipose-specific knockout, mice have increased insulin resistance and decreased brown adipose tissue–mediated glucose disposal. These data are compatible with the concept that FGF21 functions physiologically as an insulin sensitizer under conditions of acute refeeding and overfeeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skeletal muscle, FGF21 expression, in healthy conditions, is almost undetectable, and therefore, the circulating FGF21 is predominantly produced and released by the liver.6, 12”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [12]
In the citing paper
“In skeletal muscle, FGF21 expression, in healthy conditions, is almost undetectable, and therefore, the circulating FGF21 is predominantly produced and released by the liver.6, 12”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [12]
In the citing paper
“circulating levels of FGF21 are now known to be derived primarily, if not exclusively, from the liver under physiological conditions in both rodents6 and humans7.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [6]
In the citing paper
“FGF21 treatment of isolated primary brown adipocytes, but not white adipocytes, enhances insulin-stimulated glucose uptake6.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [6]
In the citing paper
“while a lack of FGF21 exacerbates liver and metabolic dysfunction in response to high-fat diet [166]”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [166]
In the citing paper
“Notably, despite the expression of Fgf21 mRNA in these tissues, under most physiological conditions, circulating levels of FGF21 are derived primarily from the liver (46, 86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“However, when nutrients become available following a prolonged fast, FGF21 functions as a metabolic switch to facilitate the transition to the refed state by enhancing insulin-stimulated glucose uptake while acutely maintaining the actions of the fasting response (86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“These circulating levels of FGF21 are derived from the liver, as the genetic loss of Fgf21 specifically from the liver ablates plasma FGF21 levels during fasting (86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“For example, while chronic feeding of a high-fat diet clearly represents a state of cellular and mitochondrial stress for skeletal muscle, skeletal muscle does not contribute to circulating levels of FGF21 during feeding of a high-fat diet; instead, circulating levels of FGF21 are derived exclusively from the liver under these conditions (86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“Multiple studies have demonstrated that FGF21 stimulates glucose uptake in BAT in vivo (11, 27, 86, 115).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“In addition, FGF21 enhances insulin sensitivity in primary brown adipocytes (86) but not in primary white adipocytes (64, 86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
Rodríguez, C. I., Buchholz, F., Galloway, J. L., Sequerra, R., Kasper, J. S., Ayala, R., Stewart, A. F., & Dymecki, S. M. (2000) · Nature Genetics · doi:10.1038/75973 · Cited by 1,162
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
Self-citationThe metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904187106 · Cited by 704
Self-citationLin, Z., Tian, H., Lam, K. S. L., Lin, S., Hoo, R. C. L., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.005 · Cited by 691
Transcriptional Control of Adipose Lipid Handling by IRF4
Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J. R., Estall, J. L., Klein, U., Maratos–Flier, E., & Rosen, E. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.005 · Cited by 597
Dutchak, P. A., Katafuchi, T., Bookout, A. L., Choi, J. H., Yu, R. T., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell · doi:10.1016/j.cell.2011.11.062 · Cited by 537
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 589
Hansen, A. M. K., Vienberg, S. G., Lykkegaard, K., Zhao, X., Tingqing, G., Han, D., Zhang, X., Thøgersen, H., Sass‐Ørum, K., Tagmose, T. M., et al. (2018) · Biochemical Journal · doi:10.1042/bcj20180555 · Cited by 23
Markan, K. R., Boland, L. K., King-McAlpin, A. Q., Claflin, K. E., Leaman, M. P., Kemerling, M. K., Stonewall, M. M., Amendt, B. A., Ankrum, J. A., & Potthoff, M. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.02.008 · Cited by 22
Self-citationThe autocrine role of FGF21 in cultured adipocytes
Justesen, S., Haugegaard, K. V., Hansen, J. B., Hansen, H. S., & Andersen, B. (2020) · Biochemical Journal · doi:10.1042/bcj20200220 · Cited by 25
Wang, J., Chen, Y., Pan, R., Wu, C., Chen, S., Li, L., Li, Y., Yu, C., Meng, Z., & Xu, C. (2021) · Liver International · doi:10.1111/liv.14816 · Cited by 23
de Goede, P., Sen, S., Su, Y., Foppen, E., Poirel, V., Challet, É., & Kalsbeek, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103171 · Cited by 22
Yang, B. C., Wu, S. Y., & Leung, P. S. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.129 · Cited by 22
Role of GPRC6A in Regulating Hepatic Energy Metabolism
Pi, M., Xu, F., Ye, R.-S., Nishimoto, S. K., Williams, R. W., Williams, R. W., Lu, L., & Quarles, L. D. (2019) · Scientific Reports · doi:10.1038/s41598-020-64384-8 · Cited by 22
Fibroblast growth factor 21: A “rheostat” for metabolic regulation?
She, Q.-Y., Bao, J., Wang, H.-Z., Liang, H., Huang, W., Wu, J., Zhong, Y.-W., Ling, H., Li, A., & Qin, S.-L. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155166 · Cited by 22
The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone
Zi, C., Wang, D., Gao, Y., & He, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1104943 · Cited by 23
Hepatic-specific PPARα-FGF21 action in NAFLD
Piccinin, E., & Moschetta, A. (2016) · Gut · doi:10.1136/gutjnl-2016-311408 · Cited by 22
Valdecantos, M. P., Ruiz, L., Folgueira, C., Rada, P., Gómez‐Santos, B., Solas, M., Hitos, A. B., Field, J., Francisco, V., Escalona-Garrido, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54080-w · Cited by 24
FGF21 Alleviates Hepatic Endoplasmic Reticulum Stress under Physiological Conditions
Maruyama, R., Shimizu, M., Hashidume, T., Inoue, J., Itoh, N., & Sato, R. (2018) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.64.200 · Cited by 21
Reduced insulin signaling in neurons induces sex-specific health benefits
Baghdadi, M., Nespital, T., Mesaros, A., Buschbaum, S., Withers, D. J., Grönke, S., & Partridge, L. (2023) · Science Advances · doi:10.1126/sciadv.ade8137 · Cited by 24
Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77
Zhou, F., Bai, M., Zhang, Y., Zhu, Q., Zhang, L., Zhang, Q., Wang, S., Zhu, K., Liu, Y., Wang, X., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.070 · Cited by 22
Lewis, J. E., Monnier, C., Marshall, H. J., Fowler, M. J., Green, R., Cooper, S., Chiotellis, A., Luckett, J., Perkins, A. C., Coşkun, T., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.009 · Cited by 25
Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus
Guo, C. Y., Zhao, L., Li, Y., Deng, X., & Yuan, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29879 · Cited by 21
Chu, Y., Yang, S., & Chen, X. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108844 · Cited by 21
Advances in Adipose Tissue Biology
Corvera, S., Rajan, A., Townsend, K. L., Shamsi, F., Wu, J., Svensson, K. J., Zeltser, L. M., Collins, S., Reis, T., Tseng, Y., et al. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf032 · Cited by 27
Hypoxia-Induced Adipose Lipolysis Requires Fibroblast Growth Factor 21
Wu, G., Liu, Y., Feng, W., An, X., Lin, W., & Tang, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01279 · Cited by 20
Comparison of Beneficial Metabolic Effects of Liraglutide and Semaglutide in Male C57BL/6J Mice
Liu, D., Gu, J., Shao, W., Pang, J., Qian, X., & Jin, T. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.08.012 · Cited by 21
Gao, F., Chen, M., Yu, J., Xu, L., Yu, L., Jiang, H., & Gu, Z. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.104957 · Cited by 21
Guo, J., Chen, H.-H., Lee, W., Chen, S., Lee, S., & Chen, C. (2022) · Nutrients · doi:10.3390/nu14030645 · Cited by 21
The role of innate immunity in the regulation of brown and beige adipogenesis
Alexaki, V. I., & Chavakis, T. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9342-7 · Cited by 21
Örd, T., Örd, D., & Örd, T. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.01.014 · Cited by 20
Ippagunta, S. M., Kharitonenkov, A., Adams, A. C., & Hillgartner, F. B. (2018) · Journal of Nutrition · doi:10.1093/jn/nxy022 · Cited by 21
Tapía, P., Fernández‐Galilea, M., Robledo, F., Mardones, P., Galgani, J. E., & Cortés, V. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12389 · Cited by 21
Carbohydrate Availability as a Regulator of Energy Balance With Exercise
Gonzalez, J. T., Betts, J. A., & Thompson, D. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000196 · Cited by 20
Current understanding and controversies on the clinical implications of fibroblast growth factor 21
Badakhshi, Y., & Jin, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1864278 · Cited by 20
Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in citrin deficiency
Tiwari, V., Jin, B., Sun, O., Gonzalez, E. D. J. L., Chen, M.-H., Wu, X., Shah, H., Zhang, A., Herman, M. A., Spracklen, C. N., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01399-3 · Cited by 20
Higgins, C. B., Adams, J. A., Ward, M. H., Greenberg, Z. J., Milewska, M., Sun, J., Zhang, Y., Paracatu, L. C., Dong, Q., Ballentine, S. J., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102835 · Cited by 19
The SLC25A47 locus controls gluconeogenesis and energy expenditure
Yook, J.-S., Taxin, Z. H., Yuan, B., Oikawa, S., Auger, C., Mutlu, B., Puigserver, P., Hui, S. T., & Kajimura, S. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216810120 · Cited by 20
Sui, Y., Liu, Q., Xu, C., Ganesan, K., Ye, Z., Li, Y., Wu, J., Du, B., Gao, F., Song, C., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-023-06386-8 · Cited by 19
Impact of FGF21 on glycemic control
Strowski, M. Z. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0001 · Cited by 20
Transcriptional control and hormonal response of thermogenic fat
Emont, M. P., Yu, H. M., & Wu, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0026 · Cited by 19
Vispute, S. G., Bu, P., Le, Y., & Cheng, X. (2017) · Toxicology · doi:10.1016/j.tox.2017.01.009 · Cited by 19
Brooks, N. E., Hjortebjerg, R., Henry, B. E., List, E. O., Kopchick, J. J., & Berryman, D. E. (2016) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.08.003 · Cited by 18
Jin, T. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.11.002 · Cited by 19
FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition
Reilly, S. M., Abu-Odeh, M., Ameka, M., DeLuca, J. H., Naber, M. C., Dadpey, B., Ebadat, N., Gomez, A. V., Peng, X., Poirier, B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145546 · Cited by 18
Self-citationEffects and possible mechanisms of intermittent fasting on health and disease: a narrative review
Li, Z., Huang, L., Luo, Y., Yu, B., & Tian, G. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad026 · Cited by 21
Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV
Ramirez, C. E., Agarwal, N., Cox, A. R., Hartig, S. M., Lake, J. E., & Balasubramanyam, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad028 · Cited by 21
Mutsnaini, L., Kim, C.-S., Kim, J., Joe, Y., Chung, H., Choi, H., Roh, E., Kim, M., & Yu, R. (2019) · Inflammation Research · doi:10.1007/s00011-019-01222-2 · Cited by 18
Cardiac myocyte KLF5 regulates body weight via alteration of cardiac FGF21
Pol, C. J., Pollak, N. M., Jurczak, M. J., Zacharia, E. M., Karagiannides, I., Kyriazis, I. D., Ntziachristos, P., Scerbo, D. A., Brown, B. R., Aifantis, I., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.010 · Cited by 18
Gourronc, F. A., Markan, K. R., Kulhánková, K., Zhu, Z., Sheehy, R. M., Quelle, D. E., Zingman, L. V., Kurago, Z., Ankrum, J. A., & Klingelhutz, A. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236741 · Cited by 19
Self-citationZhang, Y., Higgins, C. B., Tine, B. A. V., Bomalaski, J. S., & DeBosch, B. J. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100498 · Cited by 19
Dual effects of fibroblast growth factor 21 on hepatic energy metabolism
Samms, R. J., Murphy, M., Fowler, M. J., Cooper, S., Emmerson, P. J., Coşkun, T., Adams, A. C., Kharitonenkov, A., Ebling, F. J. P., & Tsintzas, K. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0334 · Cited by 17
Adipokines and Metabolic Regulators in Human and Experimental Pulmonary Arterial Hypertension
Papathanasiou, A. E., Spyropoulos, F., Michael, Z., Joung, K. E., Briana, D. D., Malamitsi‐Puchner, A., Mantzoros, C. S., & Christou, H. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031435 · Cited by 17
Mizumoto, T., Yoshizawa, T., Sato, Y., Ito, T., Tsuyama, T., Satoh, A., Araki, S., Tsujita, K., Tamura, M., Oike, Y., et al. (2022) · Cells · doi:10.3390/cells11223609 · Cited by 18
Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
Antonellis, P. J., Hayes, M. P., & Adams, A. C. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00077 · Cited by 17
Fletcher, J. A., Linden, M. A., Sheldon, R. D., Meers, G. M.-E., Morris, E. M., Butterfield, A. M., Perfield, J. W., Rector, R. S., & Thyfault, J. P. (2017) · Experimental Physiology · doi:10.1113/ep086629 · Cited by 17
What Can ‘Brown-ing’ Do For You?
Singh, A. M., & Dalton, S. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.03.002 · Cited by 18
Tomé, D., Chaumontet, C., Even, P. C., Darcel, N., Thornton, S. N., & Azzout‐Marniche, D. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05990 · Cited by 19
Sex-specific brain erythropoietin regulation of mouse metabolism and hypothalamic inflammation
Dey, S., Cui, Z., Gavrilova, O., Zhang, X., Gassmann, M., & Noguchi, C. T. (2020) · JCI Insight · doi:10.1172/jci.insight.134061 · Cited by 17
Welles, J. E., Dennis, M. D., Jefferson, L. S., & Kimball, S. R. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00555.2019 · Cited by 17
Kawanishi, H., Ohashi, K., Ogawa, H., Otaka, N., Takikawa, T., Fang, L., Ozaki, Y., Takefuji, M., Murohara, T., & Ouchi, N. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235362 · Cited by 17
Fibroblast growth factor 21 in dairy cows: current knowledge and potential relevance
Eder, K., Geßner, D. K., & Ringseis, R. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00621-y · Cited by 18
Schlessinger, K., Li, W., Tan, Y., Liu, F., Souza, S. C., Tozzo, E., Liu, K., Thompson, J. R., Wang, L., & Muise, E. S. (2015) · Obesity · doi:10.1002/oby.21153 · Cited by 17
Zarei, M., Pujol, E., Quesada‐López, T., Villarroya, F., Barroso, E., Vázquez, S., Pizarro‐Delgado, J., Palomer, X., & Vázquez‐Carrera, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14678 · Cited by 17
Alizadeh‐Fanalou, S., Babaei, M., Hosseini, A., Azadi, N. A., Nazarizadeh, A., Shojaii, A., Borji, M., Malekinejad, H., & Bahreini, E. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112331 · Cited by 17
Soundarrajan, M., Deng, J., Kwasny, M., Rubert, N. C., Nelson, P. C., Abou-el-Seoud, D., Landsberg, L., & Neff, L. M. (2020) · Adipocyte · doi:10.1080/21623945.2020.1724740 · Cited by 20
Nonogaki, K., & Kaji, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-72975-8 · Cited by 16
Protein-Restricted Diets and Their Impact on Metabolic Health and Aging
Kim, S. Q., Spann, R. A., Hill, C. M., Berryman, C. E., Berthoud, H., McDougal, D. H., He, Y., Münzberg, H., Yu, S., & Morrison, C. D. (2025) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-121624-114918 · Cited by 17
Men, L., Hui, W., Guan, X., Song, T., Wang, X., Zhang, S., & Chen, X. (2020) · Genes · doi:10.3390/genes11070720 · Cited by 16
Farokhnia, M., Wang, T., Jourdan, T., Godlewski, G., Farinelli, L. A., Kunos, G., & Leggio, L. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109809 · Cited by 16
Mayer, A. L., Zhang, Y., Feng, E. H., Higgins, C. B., Adenekan, O., Pietka, T., Beatty, W. L., & DeBosch, B. J. (2018) · Endocrinology · doi:10.1210/en.2017-03150 · Cited by 16
Ojeda, M. L., Nogales, F., Carrasco, J. A., Gallego‐López, M. D. C., Carreras, O., Alcudia, A., & Pajuelo, E. (2023) · Antioxidants · doi:10.3390/antiox12051123 · Cited by 17
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms
Richter, M. M., Kemp, I. M., Heebøll, S., Winther‐Sørensen, M., Kjeldsen, S. A. S., Jensen, N. J., Nybing, J. D., Linden, F. H., Høgh‐Schmidt, E., Boesen, M., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155915 · Cited by 15
Trusz, G. J. (2024) · Differentiation · doi:10.1016/j.diff.2024.100793 · Cited by 15
In vivo protective effect of adipsin-deficiency on spontaneous knee osteoarthritis in aging mice
Paré, F., Tardif, G., Fahmi, H., Ouhaddi, Y., Pelletier, J., & Martel‐Pelletier, J. (2020) · Aging · doi:10.18632/aging.102784 · Cited by 16
Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury
Christidis, G., Karataylı, E., Hall, R. A., Weber, S. N., Reichert, M., Hohl, M., Qiao, S., Boehm, U., Lütjohann, D., Lammert, F., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157898 · Cited by 15
Buell‐Acosta, J. D., Garcés, M. F., Baños, A. J. P., Ángel‐Müller, E., Páez, M. C., Eslava-Schmalbach, J. H., Escobar-Córdoba, F., Caminos-Cepeda, S. A., Lacunza, E., Castano, J. P., et al. (2022) · Cells · doi:10.3390/cells11142251 · Cited by 15
Fu, Z., Lundgren, P., Pivodic, A., Yagi, H., Harman, J. C., Yang, J., Ko, M., Neilsen, K., Talukdar, S., Hellström, A., et al. (2023) · Angiogenesis · doi:10.1007/s10456-023-09872-x · Cited by 15
Moure, R., Domingo, P., Villarroya, J., Gasa, L., Gallego-Escuredo, J. M., Quesada‐López, T., Morón‐Ros, S., Maroto, A. F., Mateo, G. M., Domingo, J. C., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00029-18 · Cited by 15
Exploring endocrine FGFs - structures, functions and biomedical applications
Phan, P. (2024) · International Journal of Biochemistry and Molecular Biology · doi:10.62347/palk2137 · Cited by 16
Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet
Ernesti, I., Baratta, F., Watanabe, M., Risi, R., Camajani, E., Persichetti, A., Tuccinardi, D., Mariani, S., Lubrano, C., Genco, A., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1058364 · Cited by 19
FGF21 mediating the Sex-dependent Response to Dietary Macronutrients
Sauza, K. A. S., & Ryan, K. K. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae363 · Cited by 14
Hepatic function of glucagon-like peptide-1 and its based diabetes drugs
Feng, J. N., & Jin, T. (2024) · Medical Review · doi:10.1515/mr-2024-0018 · Cited by 17
Ketogenic diet with aerobic exercise can induce fat browning: potential roles of β-hydroxybutyrate
Kim, S., Park, D., Moon, S., Gu, B., Mantik, K. E. K., Kwak, H., Ryu, J.-K., & Kang, J.-H. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1443483 · Cited by 14
FAP finds FGF21 easy to digest
Gillum, M. P., & Potthoff, M. J. (2016) · Biochemical Journal · doi:10.1042/bcj20160004 · Cited by 14
Self-citationKiluk, P., Baran, A. M., Kaminski, T. W., Maciaszek, M., & Flisiak, I. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122206 · Cited by 15
Ketone body and FGF21 coordinately regulate fasting-induced oxidative stress response in the heart
Kawakami, R., Sunaga, H., Iso, T., Kaneko, R., Koitabashi, N., Obokata, M., Harada, T., Matsui, H., Yokoyama, T., & Kurabayashi, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-10993-4 · Cited by 14
Hua, L., Li, J., Yang, Y., Jiang, D., Jiang, X., Han, X., Jin, C., Feng, B., Che, L., Xu, S., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202202031r · Cited by 14
Even, P. C., Gehring, J., & Tomé, D. (2021) · Obesity Reviews · doi:10.1111/obr.13194 · Cited by 17
Tryptophan Hydroxylase 1 Regulates Tryptophan and Its Metabolites
Nonogaki, K., & Kaji, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093978 · Cited by 14
Zhou, Z., Zhang, H., Tao, Y., Zang, J., Zhao, J., Li, H., Wang, Y., Wang, T., Zhao, H., Wang, F., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102877 · Cited by 13
Bjorkman, S. H., Marti, A., Jena, J., García-Peña, L. M., Weatherford, E. T., Kato, K. M., Koneru, J., Chen, J., Sood, A., Potthoff, M. J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52004-8 · Cited by 13
Self-citationHead Over Hepatocytes for FGF21
Potthoff, M. J., & Finck, B. N. (2014) · Diabetes · doi:10.2337/db14-1185 · Cited by 13
Self-citationKondeti, S., Dinesh Yadav, D. M., Muralidhar, M. N., Prasad, S. M. V. K., Nemani, H., & Kalashikam, R. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111252 · Cited by 12
Jois, T., & Sleeman, M. W. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12473 · Cited by 14
Choi, H. S., Lee, H. A., Kim, S.-W., & Cho, E.-H. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.2.273 · Cited by 13
Flis, M., Rodziewicz-Flis, E. A., Micielska, K., Kortas, J. A., Jaworska, J., Borkowska, A., Sansoni, V., Perego, S., Lombardi, G., & Ziemann, E. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5015 · Cited by 16
Liu, X., Graham, Z., Harlow, L., Pan, J., Azulai, D., Bauman, W. A., Yarrow, J. F., & Cardozo, C. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.668984 · Cited by 12
Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis
Yan, B., Ma, S., Yan, C., & Han, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1108234 · Cited by 12
Hu, Y., Li, J., Li, X., Wang, D., Xiang, R., Liu, W., Hou, S., Zhao, Q., Yu, X., Xu, M., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155661 · Cited by 12
Richter, M. M., Thomsen, M. N., Skytte, M. J., Kjeldsen, S. A. S., Samkani, A., Frystyk, J., Magkos, F., Holst, J. J., Madsbad, S., Krarup, T., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae008 · Cited by 13
Characterization of FGF21 Sites of Production and Signaling in Mice
Sullivan, A. I., Jensen-Cody, S. O., Claflin, K. E., Vorhies, K., Flippo, K. H., & Potthoff, M. J. (2024) · Endocrinology · doi:10.1210/endocr/bqae120 · Cited by 11
Self-citationHepatocyte Period 1 dictates oxidative substrate selection independent of the core circadian clock
Sun, J., Zhang, Y., Adams, J. A., Higgins, C. B., Kelly, S. C., Zhang, H., Cho, K., Johnson, U. G., Swarts, B. M., Wada, S.-I., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114865 · Cited by 13
Chen, S., Li, H., Zhang, J., Jiang, S., Zhang, M., Xu, Y., Dong, K., Yang, Y., Fang, Q., & Jia, W. (2017) · BioMed Research International · doi:10.1155/2017/8402035 · Cited by 12
Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma
Florea, A., Harris, R. B., Klimentidis, Y. C., Kohler, L. N., Jurutka, P. W., & Jacobs, E. T. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00515-8 · Cited by 11
Domouzoglou, E. M., Vlahos, A. P., Cholevas, V., Papafaklis, M. I., Chaliasos, N., Siomou, E. C., Michalis, L. K., Tsatsoulis, A. A., & Naka, K. Κ. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2040258.129 · Cited by 12
Molecular methods to study protein trafficking between organs
Kreissl, F. K., Banki, M. A., & Droujinine, I. A. (2022) · PROTEOMICS · doi:10.1002/pmic.202100331 · Cited by 11
Metadata
- Authors
- Markan, K. R., Naber, M. C., Ameka, M. K., Anderegg, M. D., Mangelsdorf, D. J., Kliewer, S. A., Mohammadi, M., & Potthoff, M. J.
- Affiliations
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Corresponding author
- Potthoff, Matthew J.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-11-13
- Volume
- 63
- Issue
- 12
- Pages
- 4057-4063
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC4238010
- OpenAlex
- W2133706171
- Cited by
- 590
- References
- 23
- Citations by year
- 2026: 26 · 2025: 42 · 2024: 41 · 2023: 60 · 2022: 56 · 2021: 64 · 2020: 62 · 2019: 60 · 2018: 44 · 2017: 53 · 2016: 51 · 2015: 28 · 2014: 3
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5p60dk020593-31)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK020593, DK 20593, R01DK067158, P30DK020593)
- National Institute of Dental and Craniofacial Research (R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- FGF21, insulin sensitivity, insulin resistance, refeeding, overfeeding, fasting, glucose uptake, brown adipose tissue, energy homeostasis, obesity, liver-specific knockout
- MeSH terms
- Adipose Tissue, Animals, Blood Glucose, Adipose Tissue, Brown, Fasting, Fibroblast Growth Factors, Glucose, Insulin, Insulin Resistance, Liver, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review